Patricia’s commitment to the healthcare industry spans more than 25 years. Prior to joining Viveve, she served as the CEO of Prescient Medical, Inc., a privately held company that developed diagnostic imaging catheters and coronary stents designed to reduce deaths from heart attacks. Before PMI she was the CEO of SomaLogic, a molecular diagnostic company dedicated to developing protein signature arrays. Patricia also managed several business units at Ortho-Clinical Diagnostics, a Johnson & Johnson company, and served in key executive positions at Dade Behring, a clinical diagnostics firm. In addition, she was director of cardiology systems at Cordis, a Johnson & Johnson company renowned for pioneering vascular disease treatments. There, she was responsible for launching the PALMAZ-SCHATZ® balloon-expandable Stent, the first stent to achieve over a billion dollars in sales. Patricia received a B.S.E. degree in Biomedical Engineering from Duke University and completed executive business education programs at Harvard University, Massachusetts Institute of Technology, Columbia University and Northwestern University. She received the Distinguished Alumnus award from Pratt School of Engineering at Duke University in 2016.
Scott joined Viveve as Chief Financial Officer in January 2013. His 20 year career in corporate finance and strategy for the life science industry brings a wealth of finance experience to our organization. Prior to joining Viveve, he was Chief Financial Officer of Aastrom Biosciences, a publicly traded, cardiovascular cell therapy company. Before Aastrom, he spent six years as Chief Operating and Financial Officer for Prescient Medical, a privately held company that developed diagnostic imaging catheters and coronary stents designed to reduce deaths from heart attacks. Prior to Prescient, he spent several years as a financial consultant for two publicly traded biotech companies, Scios, Inc. – a Johnson & Johnson company and Alteon, Inc. He began his career in corporate finance as an investment banker in the Healthcare and M&A groups at Lehman Brothers Inc., where he focused on mergers and acquisitions and financings for the life science industry. At Lehman, he successfully executed over $5 billion in transactions for medical device and biotech companies. He began his career as a Director of Neurophysiology for Biotronic, Inc. Scott received a B.S. from the University of Michigan and an M.P.H. in Health Management with Honors from the Yale University School of Medicine and School of Management.
Prior to joining Viveve as Chief Business Officer and President, Jim was the Senior Vice President of Global Sales at Ulthera, Inc. through April, 2014. He was the third employee to join the company in October, 2006 as Senior Vice President of Sales and Marketing. While at Ulthera, he helped grow the company from 3 to 165 employees and established a global distribution network that included 42 distributors, covering 52 countries. Ulthera was purchased by Merz Aesthetics for $600 million in 2014. Before joining Ulthera, Mr. Atkinson served as Vice President of Sales and Marketing for the Cardiac Surgery Division at St. Jude Medical, where his responsibilities included launching the Biocor stented tissue valve, recognized as the fastest growing heart valve brand in the industry. Prior to St. Jude Medical, he served as Vice President of Sales for Medtronic Vascular, a $200 million division of Medtronic, Inc. Mr. Atkinson's entrepreneurial spirit led him to co-found and serve as Vice President of Sales and Business Development for Medical Simulation Corporation, the leading developer of state-of-the-art simulation technologies and services for the cardiology, cardiac surgery and nursing industries. His career began as a sales representative at Ethicon Endosurgery where he progressed through positions of increasing responsibility to Regional Manager.
Suzon Lommel has more than 30 years of experience in the medical device industry developing regulatory and quality systems. She currently serves as the Senior Vice President of Regulatory and Quality Affairs at Viveve. Prior to joining Viveve, she was Global Vice President of Regulatory and Quality Affairs at Ulthera, Inc. which was acquired by Merz Aesthetics in July, 2014. Additional prior experience includes executive and senior management roles at Breathe Technologies, Inc., Foxhollow Technologies, Inc., Advanced Stent Technology, and Boston Scientific. Suzon has extensive experience with the U.S. Food and Drug Administration and international regulatory agencies. She has authored numerous 510k, IDE, PMA, and international submissions. Ms. Lommel holds a degree in Physics from Moorpark College.
Susan joined Viveve in August of 2015 as Vice President of Global Marketing. She brings decades of experience in launching and building new categories of medical devices for novel, elective consumer-driven health and wellness brands. Susan led the marketing effort for Ulthera, the first-ever FDA-cleared procedure for non-invasive skin lifting and tightening -- from inception in 2006 with 3 employees to 120 employees 6 years later and subsequent acquisition by Merz Aesthetic for $600 million. Prior to that she contributed to launching firsts in laser hair removal and laser skin resurfacing/rejuvenation (Coherent/Lumenis), radio frequency and infrared technologies for medical aesthetics (Thermage/Solta and Cutera), a time-release technology for a flagship topical pharmaceutical (Johnson & Johnson/Ortho Pharmaceuticals’ Retin-A brand), a diagnostic for detecting and monitoring osteoporosis/bone resorption (Edelman Public Relations) and the concept, innovative at the time, of in-office dispensing of pharmaceuticals and skin care (Summacare, Inc.). Her career in medical devices began as a member of the team that launched the first aesthetic medical device, an injectable for wrinkles and acne scars (Collagen Corporation/Inamed), which pioneered direct-to-consumer marketing of an FDA-cleared device. Other healthcare-related work was with Genentech (a commercialization optimization initiative) and Stanford’s Packard Children’s Hospital (Director of Community Affairs). Susan’s first job after graduating from the University of California at Berkeley was at Stanford University School of Medicine managing the research activities and publication efforts around ground-breaking advances in medical dermatology.
Debbie joined Viveve in 2015 and was promoted to Vice President of Clinical Affairs in August, 2016. She brings over 17 years of experience in life sciences including pharmaceutical, biologics, medical devices and women's reproductive health. She has extensive clinical affairs leadership experience across multiple therapeutic areas as well as experience in operations and regulatory affairs. Debbie has launched many U.S. and international trials in women's health, immunology, urology, orthopedics and dermatology. In connection with this work she has published numerous articles in peer-reviewed publications.
Prior to joining Viveve, Debbie served as the Director of Clinical Research for Medtronic Spine and Biologics (MDT), Medtronic's second largest business, and managed a high profile biologic. She was Executive Director of Clinical Operations at OV Clinical Trials in Colorado and Director of Research and Development at Alita Pharmaceuticals. As an Associate Director and then Director of Clinical Operations at Duramed Research, Inc., a subsidiary of Barr Pharmaceuticals, Debbie focused on women's health programs, including bringing Plan B emergency contraception OTC. Previous to these executive management roles, she was Director of Scientific Affairs at Women's Capital Corporation responsible for operations, safety, FDA submissions, marketing and external collaboration, which was preceded by her role as Research Associate at The David and Lucile Packard Foundation.
Debbie received her Bachelor of Science in Chemistry degree from the University of Michigan and earned her Doctorate in Biochemistry from the Stanford University School of Medicine.
Jim joined Viveve as Vice President of Finance in July 2014. He brings over twenty years of accounting and finance experience in both industry and public accounting to the organization. Prior to joining Viveve, he provided accounting, finance and business consulting services for various biotech companies. From 2010 to 2012 he served as Vice President of Finance and Administration for Auxogyn, Inc., a privately held medical technology company focused on advancing women’s reproductive health by translating scientific discoveries in early embryo development into clinical solutions that improve patient outcomes in vitro fertilization (IVF) procedures. He served as Director of Finance and Vice President of Finance 2004 to 2010 for Micrus Endovascular, Inc., a company which develops, manufactures and markets both implantable and disposable medical devices used in the treatment of cerebral vascular diseases. Prior to Micrus Endovascular, Jim served at Genitope Corporation as Corporate Controller, a biotechnology company focused on the research and development of novel immunotherapies for the treatment of cancer. From 1995 to 2001, he served in management positions for high technology companies including Extricity, Inc., InVision Technologies, Inc., and Truevision, Inc. Jim was in the audit practice of Price Waterhouse, LLP from 1987 to 1995. He received his Bachelor of Business Administration with a concentration in accounting from the University of Texas at Austin and is a Certified Public Accountant.
Sean joined Viveve as Vice President of U.S. Sales in September, 2016 and brings extensive experience in medical device and aesthetic industry sales, commercial team organization, development, and management. Most recently, Sean served as Director of Sales, Merz North America, Aesthetic Device Division where he was responsible for capital and consumable sales of $100M annually directing a team of 50 regional and direct sales professionals. He led the commercial launch of the Cellfina™ System that in 12 months became the market leader generating over $15M in sales. A Regional Sales Director at Ulthera, Inc., Sean managed a team selling new ultrasound tissue lifting technology and capital equipment to physicians in the aesthetic marketplace earning top sales awards personally and with the team he led. At Zeltiq, Inc. he served as an Area Sales Manager and launched CoolSculpting®, again earning sales revenue and management awards. Prior to this, Sean had five years as a successful Area Sales Manager at Lumenis, Inc.
A known and respected sales leader in the aesthetic marketplace, Sean has consistently received annual awards and recognition for top sales dollar volume, region and territory revenue, new technology and product launches in addition to sales management and business development accomplishments.
Sean earned his Bachelor of Science in Communications from the University of Arizona.
Lori has over 20 years of leadership experience in human resources and strategic talent management in healthcare and technology industries. Prior to joining Viveve in May 2017, she was Vice President of Talent Management and Chief Administrative Officer at The Breakaway Group, a Colorado-based business that develops simulation education of HIT applications for over 1 million healthcare provider end users. Lori has held senior leadership positions demonstrating success in creating and implementing effective human capital and operational strategies in support of organizations’ mission, values and goals. She served as a human resources executive at the Association of periOperative Registered Nurses (AORN) and Evolving Systems, Inc., a software company which tripled in size prior to their IPO. Early in her career, Lori held management and sales executive positions in the cosmetics and fragrance industries with Estee Lauder and Riviera Concepts. She received her Bachelor of Arts degree in Sociology at Colorado State University and completed HR executive and business education programs at Stanford University and Vassar College.
Jim joined Viveve as Vice President of Regulatory Affairs and Quality in November 2015. He brings over 30 years of experience in the medical device industry having worked for small startups as well as large Fortune 500 companies. Prior to joining Viveve, Jim served as Senior Director of Regulatory Affairs and Quality Assurance for ViewRay, Inc., a privately held medical device company manufacturing MRI/RT systems for the treatment of cancerous tumors in the body. While at ViewRay, he achieved both ISO13485 and CE Mark certifications as well as clearances in several Asian countries. Previously, Jim served as Sr. Director RA/QA/Operations for Restoration Robotics, a privately held medical device company specializing in a vision controlled surgical robotic system used in the hair transplantation field. While at Restoration Robotics, he led efforts to gain ISO13485 and CE Mark certifications as well as multiple FDA 510(k) clearances and OUS clearances in over 30 countries within the EU, Asia, and South America.
Before joining Restoration Robotics, Mr. Talbot served in senior RA/QA positions for InSound Medical, a pioneer in developing an in-the-canal hearing aid, Boston Scientific’s Fremont CA division responsible for IVUS ultrasound systems and catheters, Cutera, a leader in the aesthetic laser industry, Cytyc Surgical, a women’s health company specializing the treatment of menorrhagia, and Acuson, a leader in diagnostic ultrasound acquired by Siemens. Jim began his career working for Hewlett-Packard’s Optoelectronic Division in Palo Alto CA as a Reliability Engineer. He received his Bachelor of Arts with a major in Physics from SUNY Potsdam and attended graduate school at Syracuse University, where he majored in Physics.